Enara Bio announces the appointment of T-cell therapy leader Dr. Sophie Papa as Chief Medical Officer

/PRNewswire/ -- Enara Bio, a biotechnology company advancing novel T-cell receptor (TCR) directed immunotherapies against unconventional, shared,...

Related Keywords

London ,City Of ,United Kingdom ,Eleanor Perkin ,Frazer Hall ,Enara Bio ,Prnewswire Enara Bio ,Kevin Pojasek ,Sophie Papa ,King College London ,Sv Health Investors ,University Of Oxford ,Boehringer Ingelheim ,Cardiff University ,Foundation Trust ,Imperial College London ,Johns Hopkins School Of Medicine ,St Thomas Early Phase Trials Team ,Francis Crick Institute ,Chief Medical ,College London ,Clinical Reader ,Consultant Medical ,Early Phase Trials Team ,Dark Antigens ,Dark Antigen ,United Kingdom Based ,Johns Hopkins School ,Mark Swallow ,